IO Biotech
Stock Forecast, Prediction & Price Target
IO Biotech Financial Estimates
IO Biotech Revenue Estimates
IO Biotech EBITDA Estimates
IO Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $1.5M Low: $1.5M High: $1.5M avg. 0% | Avg: $10.11B Low: $10.11B High: $10.11B avg. 674542.41% | Avg: $110.12M Low: $110.12M High: $110.12M avg. -98.91% | Avg: $240.05M Low: $240.05M High: $240.05M avg. 117.98% |
Net Income
% change YoY
| $-67.87M N/A | $-71.45M -5.27% | $-86.08M -20.46% | Avg: $-122.22M Low: $-60.95M High: $-43.10M avg. -41.98% | Avg: $-134.54M Low: $-60.08M High: $-41.79M avg. -10.07% | Avg: $-33.52M Low: $-33.52M High: $-33.52M avg. 75.08% | Avg: $-10.66M Low: $-10.66M High: $-10.66M avg. 68.18% |
EBITDA
% change YoY
| $-67.76M N/A | $-70.01M -3.31% | $-91.44M -30.60% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$2.36 N/A | -$2.48 -5.08% | -$1.98 20.16% | Avg: -$1.18 Low: -$1.4 High: -$0.99 avg. 40.57% | Avg: -$1.11 Low: -$1.38 High: -$0.96 avg. 5.38% | Avg: -$0.77 Low: -$0.77 High: -$0.77 avg. 30.83% | Avg: -$0.25 Low: -$0.25 High: -$0.25 avg. 68.18% |
Operating Expenses
% change YoY
| $41.23M N/A | $71.42M 73.21% | $91.44M 28.02% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is IO Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.80% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -60.95M, average is -122.22M and high is -43.10M.
What is IO Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 168640.37% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $1.5M, average is $1.5M and high is $1.5M.
What is IO Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 36.24% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.4, average is -$1.18 and high is $-0.99.